Olfactory dysfunction in Parkinson's disease

Journal of Neurology

Volumn 254, Issue SUPPL. 4, 2007, Pages

  Takeda, Atsushi ^a   Kikuchi, Akio ^a   Matsuzaki Kobayashi, Michiko ^a   Sugeno, Naoto ^a   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Odor; Olfaction; Parkinsonism; Smell

Indexed keywords

DOPAMINE;

CLINICAL EVALUATION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; EARLY DIAGNOSIS; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; ODOR; OLFACTOMETRY; OLFACTORY SYSTEM; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; SMELLING DISORDER; SYMPTOM;

EID: 34648833764     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-4002-1     Document Type: Conference Paper

References (55)

1. Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson's disease. J Chronic Dis 28(9):493-497
2. Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson's disease a primary olfactory disorder? Qjm 92(8):473-480
3. Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 55(1):84-90
4. Parkinson J (2002) An essay on the shaking palsy. London: Sherwood: Neely and Jones, 1817. 14(2):223-236; discussion 222
5. Zelano C, Sobel N (2005) Humans as an animal model of systems-level organization of olfaction. Neuron 48(3):431-454
6. Buck L (1992) A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 47:39-51
7. Ache BW, Young JM (2005) Olfaction: diverse species, conserved principles. Neuron 48(3):417-430
8. Mombaerts P (2004) Genes and ligands for odorant, vomeronasal and taste receptors. Nat Rev Neurosci 5(4):263-278
9. Doty RL (1989) Influence of age and age-related diseases on olfactory function. Ann N Y Acad Sci 561:76-86
10. Kobal G, Klimek L, Wolfensberger M, Gudziol H, Temmel A, Owen CM, Seeber H, Pauli E, Hummel T (2000) Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 257(4):205-211
11. Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32(3):489-502
12. Doty RL, Marcus A, Lee WW (1996) Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 106(3 Pt 1):353-356
13. Kondo H, Matsuda T, Hashiba M, Baba S (1998) A study of the relationship between the T&T olfactometer and the University of Pennsylvania Smell Identification Test in a Japanese population. Am J Rhinol 12(5):353-358
14. Furukawa M, Kamide M, Miwa T, Umeda R (1988) Significance of intravenous olfaction test using thiamine propyldisulfide (Alinamin) in olfactometry. Auris, Nasus, Larynx 15(1):25-31
15. Simmen D, Briner HR (2006) Olfaction in rhinology-methods of assessing the sense of smell. Rhinology 44(2):98-101
16. Amoore JE, Venstrom D, Davis AR (1968) Measurement of specific anosmia. Percept Mot Skills 26(1):143-164
17. Ward CD, Hess WA, Calne DB (1983) Olfactory impairment in Parkinson's disease. Neurology 33(7):943-946
18. Quinn NP, Rossor MN, Marsden CD (1987) Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 50(1):88-89
19. Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38(8):1237-1244
20. Doty RL, Roklan M, Deems DA, Reynolds C, Stellar S (1989) The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol 25(2):166-171
21. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55(2):138-142
22. Murofushi T, Mizuno M, Osanai R, Hayashida T (1991) Olfactory dysfunction in Parkinson's disease. ORL J Otorhinolaryngol Relat Spec 53(3):143-146
23. Muller A, Mungersdoft M, Reichmann H, Strehle G, Hummel T (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9(5):521-524
24. Westervelt HJ, Stern RA, Tremont G (2003) Odor identification deficits in diffuse Lewy body disease. Cogn Behav Neurol 16(2):93-99
25. Doty RL, Reyes PF, Gregor T (1987) Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 18:597-600
26. Lehrner JP, Brucke T, Dal-Bianco P, Gatterer G, Kryspin-Exner I (1997) Olfactory functions in Parkinson's disease and Alzheimer's disease. Chem Senses 22:105-110
27. McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD (2001) Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 70(6):739-743
28. Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128(Pt 1):126-137
29. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91(4):247-250
30. Doty RL, Golbe LI, Mckeown DA, Stern MB, Lehrach CM, Crawford D (1993) Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43(5):962-965
31. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ (2004) Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. J Neurol Neurosurg Psychiatry 75(12):1749-1752
32. Khan NL, Katzenschlager R, Watt H, Bhatia KP, Wood NW, Quinn N, Lees AJ (2004) Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson's disease. Neurology 62:1224-1226
33. Doty RL, Singh A, Tetrud J, Laugston JW (1992) Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32(1):97-100
34. Daniel SE, Hawkes CH (1992) Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 340(8812):186
35. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1-III/5
36. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197-211
37. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318(1):121-134
38. Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125(Pt 11):2431-2445
39. Hoogland P, Van den Berg R, Huisman E (2003) Misrouted olfactory fibres and ectopic olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients. Neuropathol Appl Neurobiol 29(3):303-311
40. Huisman E, Uylings HB, Hoogland PV (2004) A 100 % increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 19(6):687-692
41. Roth J, Radil T, Ruzicka E, Jech R, Tichy J (1998) Apomorphine does not influence olfactory thresholds in Parkinson's disease. Funct Neurol 13(2):99-103
42. Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN (2006) The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease. Exp Neurol 202(2):391-403
43. Rojo AI, Montero C, Salazar M, Close RM, Fernandez-Ruiz J, Sanchez-Gonzalez MA, de Sagarra MR, Jackson-Lewis V, Cavada C, Cuadrado A (2006) Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Eur J Neurosci 24(7):1874-1884
44. Liu B, Gao HM, Hong JS (2003) Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 111(8):1065-1073
45. Samii A, Nutt JG, Ransom BR (2004) Parkinson's disease. Lancet 363(9423):1783-1793
46. Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110(5):517-536
47. Hawkes C (2004) Olfactory testing in parkinsonism. Lancet Neurol 3(7):393-394
48. Sobel N, Thomason ME, Stappen I, Tanner CM, Tetrud JW, Bower JM, Sullivan EV, Gabrieli JD (2001) An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proc Natl Acad Sci USA 98(7):4154-4159
49. Hawkes CH, Shephard BC (1998) Olfactory evoked responses and identification tests in neurological disease. Ann N Y Acad Sci 855:608-615
50. Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62(5):436-446
51. Becker G, Muller A, Braune S, Buttner T, Benecke R, Greulich W, Klein W, Mark G, Rieke J, Thumler R (2002) Early diagnosis of Parkinson's disease. J Neurol 249(Suppl 3):III/40-III/48
52. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181-184
53. Montgomery EB Jr, Koller WC, LaMantia TJ, Newman MC, Swanson-Hyland E, Kaszniak AW, Lyons K (2000) Early detection of probable idiopathic Parkinson's disease: I Development of a diagnostic test battery. Mov Disord 15(3):467-473
54. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56(2):173-181
55. Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM (2005) Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord 20(6):687-693